- Home
- ROIV vs EWBC Comparison
ROIV vs EWBC Comparison
Compare ROIV & EWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | EWBC |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 15.8B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | ROIV | EWBC |
|---|---|---|
| Price | $22.78 | $111.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $24.31 | ★ $125.83 |
| AVG Volume (30 Days) | ★ 5.9M | 972.3K |
| Earning Date | 02-06-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 9.52 |
| Revenue | $20,329,000.00 | ★ $2,697,061,000.00 |
| Revenue This Year | N/A | $5.52 |
| Revenue Next Year | $741.42 | $2.71 |
| P/E Ratio | ★ N/A | $11.70 |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $8.73 | $68.27 |
| 52 Week High | $23.91 | $119.73 |
Technical Indicators
Market Signals| Indicator | ROIV | EWBC |
|---|---|---|
| Relative Strength Index (RSI) | 56.31 | 43.26 |
| Support Level | $22.50 | $111.96 |
| Resistance Level | $23.20 | $117.84 |
| Average True Range (ATR) | 0.75 | 2.94 |
| MACD | -0.01 | -0.69 |
| Stochastic Oscillator | 63.73 | 3.62 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.